Gardasil replaces Cervarix in immunisation schedule from September 2012

The human papillomavirus (HPV) vaccine used in the National Immunisation Programme will change from Cervarix to Gardasil on 1 September 2012.

HPV vaccination coverage in England is among the highest in the world | SCIENCE PHOTO LIBRARY
HPV vaccination coverage in England is among the highest in the world | SCIENCE PHOTO LIBRARY

Until this time, the Department of Health advises that Cervarix should continue to be used in eligible girls. For courses not completed by the end of the academic year, Cervarix should be used to complete the course in the next school year. It is important that all three doses are given and that the second and third doses are given at least one month apart. Courses should be completed by April 2013, when most Cervarix stock expires.

Increased protection

Gardasil provides protection against HPV types that cause genital warts (types 6 and 11) in addition to those responsible for cervical cancer (16 and 18).

Ordering

Gardasil is expected to be available for ordering via ImmForm in August 2012, although it should not be used until 1 September 2012.

View Cervarix drug record
View Gardasil drug record

Further information:
GlaxoSmithKline
Sanofi Pasteur MSD

Want news like this straight to your inbox?
Sign up for our bulletins

Read these next

HPV vaccination schedule changes from three to two doses

HPV vaccination schedule changes from three to two doses

The MIMS summary of routine childhood immunisations...

Gardasil two-dose schedule approved

Gardasil two-dose schedule approved

The human papillomavirus (HPV) vaccine Gardasil can...

Childhood vaccination schedule added to MIMS

Childhood vaccination schedule added to MIMS

A quick-reference guide to the current UK Childhood...

Cervarix licence extended

Cervarix licence extended

The marketing authorisation for Cervarix has been updated...

Gardasil efficacy data

The summary of product characteristics (SPC) for Gardasil...



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more